Andrew Bhak

Andrew K. Bhak, Council Vice-Chair is Managing Director, Group Head in Healthcare Investment Banking at BMO Capital Markets, which follows three years at J.P. Morgan, where he was responsible for the healthcare services sector. He joined J.P. Morgan from Deutsche Bank, where he was Co-Head of Healthcare Services Investment Banking. Prior to that, Andrew was at Morgan Stanley, where he served in a similar capacity and helped to build its healthcare services investment banking franchise. He has served as advisor on more than $135 billion of financing and merger & acquisitions transactions, including HMA's $7.6 billion sale to Community Health Systems, HCA's $3.8 billion IPO, US Oncology's $2.1 billion sale to McKesson, and Quest Diagnostics' $2.0 billion acquisition of Ameripath, among others. Andrew also serves on the Advisory Board of the Yale Healthcare Conference.